本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Inhibikase Therapeutics, Inc.

2.20
-0.0550-2.44%
成交量:1.64萬
成交額:3.63萬
市值:1.63億
市盈率:-1.89
高:2.30
開:2.18
低:2.11
收:2.25
資料載入中...
2024/10/17

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/17

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/10

重要事件披露

Form 8-K - Current report
2024/10/10

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/09

重要事件披露

Form 8-K - Current report
2024/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/06

重要事件披露

Form 8-K - Current report
2024/06/25

SEC問詢函

Form CORRESP - Correspondence
2024/06/18

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/06/10

重要事件披露

Form 8-K - Current report
2024/05/20

重要事件披露

Form 8-K - Current report
2024/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/05/09

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/04/30

重要事件披露

Form 8-K - Current report
2024/04/30

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/04/25

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/04/19

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/04/19

重要事件披露

Form 8-K - Current report
2024/04/02

重要事件披露

Form 8-K/A - Current report: [Amend]